INNOSTAR ORD A (SHH) EQSW Exp: (688710.SS) stock: key figures, P/E, revenue and dividend

Health Care · China

Price
86.02 CNY
Market cap
12.13 bn CNY
P/E (2025)
–
P/S (2025)
14.95
Dividend yield
0.00 %
Net margin
-3.76 %
Return on equity (ROE)
-1.31 %
Return on assets (ROA)
-0.94 %

INNOSTAR ORD A (SHH) EQSW Exp: financials

Fiscal year20242025
Revenue1.14 bn CNY811.33 m CNY
Gross profit383.79 m CNY210.59 m CNY
Operating income193.10 m CNY22.87 m CNY
EBIT170.48 m CNY-7.76 m CNY
Net income147.78 m CNY-30.52 m CNY
Diluted EPS – continuing operations1.05 CNY-0.22 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About INNOSTAR ORD A (SHH) EQSW Exp:

Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. It offers screening, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is based in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.